{"id":2955,"date":"2025-10-21T08:41:26","date_gmt":"2025-10-21T12:41:26","guid":{"rendered":"https:\/\/medicamentquebec.ca\/?p=2955"},"modified":"2025-11-12T12:52:06","modified_gmt":"2025-11-12T17:52:06","slug":"establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer","status":"publish","type":"post","link":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en","title":{"rendered":"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles"},"content":{"rendered":"<p><strong>October 21, 2025 &#8211; Funded activities<\/strong><\/p>\n<p><!--more--><\/p>\n<p>As part of its\u00a0<em data-start=\"147\" data-end=\"179\" data-is-only-node=\"\">Vaccine Technology Innovations<\/em> program, M\u00e9dicament Qu\u00e9bec is supporting six collaborative research initiatives bringing together academia and industry partners. Discover Dr. Tabrizian\u2019s project focused on developing a platform to innovate therapeutic vaccines .<\/p>\n<p>Metastatic cancer, responsible for nearly 90% of cancer-related deaths worldwide, remains a major medical challenge. Its complexity stems from the genetic heterogeneity of tumors, the ability of cancer cells to evade the immune system, and their high adaptability. Conventional treatments such as surgery, radiotherapy, or chemotherapy offer limited solutions against metastatic mechanisms, often leading to recurrence and poor prognosis.<\/p>\n<p>In light of these limitations, therapeutic vaccines are emerging as a promising approach by mobilizing the immune system to directly target cancer cells. However, several obstacles remain, including the identification of relevant tumor antigens and the development of effective delivery systems.<\/p>\n<p>Prof. Tabrizian\u2019s activity aims to develop an innovative platform using hybrid lipid nanoparticles (hLNPs) derived from bacteria to design new RNA-based cancer vaccines. These hLNPs combine bacterial lipids with synthetic lipids, providing greater biocompatibility, stability, and RNA delivery efficiency than conventional nanoparticles. They can also be produced at scale using genetically engineered bacteria, thereby reducing manufacturing costs and enabling high-throughput screening.<\/p>\n<p>To achieve this, the activity will integrate multiple platforms for the design, characterization, evaluation, and validation of hLNPs, including:<\/p>\n<ul>\n<li>AI- and machine learning\u2013assisted design tools to optimize formulations, identify trends in data, reduce trial-and-error processes, and predict hLNP performance.<\/li>\n<li>In vitro, in vivo, and organ-on-chip analyses to validate stability, efficacy, and immune system activation.<\/li>\n<li>High-throughput screening to accelerate identification of the most promising formulations.<\/li>\n<li>Bioinformatics tools coupled with machine learning to refine candidate selection.<\/li>\n<\/ul>\n<p>This integrated multi-platform approach will accelerate the identification of the most promising RNA vaccines and facilitate their progression toward clinical trials.<\/p>\n<p>This project brings together a large multidisciplinary team:<\/p>\n<p><strong><em>Academic researchers:<\/em><\/strong><\/p>\n<ul>\n<li>Maryam Tabrizian \u2013 Full Professor, Biomedical Engineering, McGill University<\/li>\n<li>Julia Valdemarin Burnier \u2013 Assistant Professor, McGill University<\/li>\n<li>Guojun Chen \u2013 Assistant Professor, Biomedical Engineering, McGill University<\/li>\n<li>Thomas Duchaine \u2013 Full Professor, Biochemistry, Goodman Cancer Institute, McGill University, and Scientific Director of the mRNA Therapeutics Platform<\/li>\n<li>Paul Fran\u00e7ois \u2013 Full Professor, Biochemistry and Molecular Medicine, Universit\u00e9 de Montr\u00e9al, IVADO &amp; Mila<\/li>\n<li>Marc Lavertu \u2013 Associate Professor, Chemical Engineering, Polytechnique Montr\u00e9al<\/li>\n<li>Sara Mahshid \u2013 Assistant Professor, Biomedical Engineering, McGill University<\/li>\n<li>Ian Watson \u2013 Associate Professor, Biochemistry, McGill University<\/li>\n<\/ul>\n<p><strong><em>Industry partners:<\/em><\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.nanofacile.bio\/fr\">Nanofacile<\/a>, a company specializing in nanofabrication and development of innovative materials<\/li>\n<li><a href=\"https:\/\/www.rnatechnologies.com\/\">RNA Technologies &amp; Therapeutics (RNA T&amp;T)<\/a>, an expert company in the design and optimization of RNA-based technologies<\/li>\n<li><a href=\"https:\/\/beetabiomed.com\/\">Beeta Biomed<\/a>, a company focused on developing biotechnology solutions for health applications<\/li>\n<\/ul>\n<p>By combining cutting-edge approaches in bioengineering, artificial intelligence, and immunology, this activity has the potential to transform the research and development of therapeutic cancer vaccines and position Qu\u00e9bec among the world leaders in this emerging field.<\/p>\n<p>This activity is supported by the Government of Qu\u00e9bec through M\u00e9dicament Qu\u00e9bec, which is investing <strong>$0.8M<\/strong>. This contribution is supplemented by <strong>$0.4M<\/strong> from industrial partners, for a total investment of <strong>$1.2M.<\/strong><\/p>\n<p><a href=\"https:\/\/medicamentquebec.ca\/?p=2827&amp;lang=en\">Read the press release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>October 21, 2025 &#8211; Funded activities<\/p>\n","protected":false},"author":7,"featured_media":2951,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[94],"tags":[],"class_list":["post-2955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles - M\u00e9dicament Qu\u00e9bec<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles - M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"og:description\" content=\"October 21, 2025 &#8211; Funded activities\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en\" \/>\n<meta property=\"og:site_name\" content=\"M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-21T12:41:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-12T17:52:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-Dr-Tabrizian-ENG-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"St\u00e9phanie Bilodeau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"St\u00e9phanie Bilodeau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en\"},\"author\":{\"name\":\"St\u00e9phanie Bilodeau\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/person\\\/f380269566615a205fb9c18904b8b89f\"},\"headline\":\"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles\",\"datePublished\":\"2025-10-21T12:41:26+00:00\",\"dateModified\":\"2025-11-12T17:52:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en\"},\"wordCount\":519,\"publisher\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-Dr-Tabrizian-ENG-1.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en\",\"name\":\"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles - M\u00e9dicament Qu\u00e9bec\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-Dr-Tabrizian-ENG-1.png\",\"datePublished\":\"2025-10-21T12:41:26+00:00\",\"dateModified\":\"2025-11-12T17:52:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en#primaryimage\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-Dr-Tabrizian-ENG-1.png\",\"contentUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Annonce-Dr-Tabrizian-ENG-1.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/10\\\/21\\\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\\\/?lang=en#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/medicamentquebec.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicamentquebec.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"contentUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"width\":494,\"height\":266,\"caption\":\"M\u00e9dicament Qu\u00e9bec\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/person\\\/f380269566615a205fb9c18904b8b89f\",\"name\":\"St\u00e9phanie Bilodeau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"caption\":\"St\u00e9phanie Bilodeau\"},\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/author\\\/bilodeaus\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles - M\u00e9dicament Qu\u00e9bec","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/","og_locale":"fr_FR","og_type":"article","og_title":"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles - M\u00e9dicament Qu\u00e9bec","og_description":"October 21, 2025 &#8211; Funded activities","og_url":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en","og_site_name":"M\u00e9dicament Qu\u00e9bec","article_published_time":"2025-10-21T12:41:26+00:00","article_modified_time":"2025-11-12T17:52:06+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-Dr-Tabrizian-ENG-1.png","type":"image\/png"}],"author":"St\u00e9phanie Bilodeau","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"St\u00e9phanie Bilodeau","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en#article","isPartOf":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en"},"author":{"name":"St\u00e9phanie Bilodeau","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/person\/f380269566615a205fb9c18904b8b89f"},"headline":"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles","datePublished":"2025-10-21T12:41:26+00:00","dateModified":"2025-11-12T17:52:06+00:00","mainEntityOfPage":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en"},"wordCount":519,"publisher":{"@id":"https:\/\/medicamentquebec.ca\/#organization"},"image":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en#primaryimage"},"thumbnailUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-Dr-Tabrizian-ENG-1.png","articleSection":["News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en","url":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en","name":"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles - M\u00e9dicament Qu\u00e9bec","isPartOf":{"@id":"https:\/\/medicamentquebec.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en#primaryimage"},"image":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en#primaryimage"},"thumbnailUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-Dr-Tabrizian-ENG-1.png","datePublished":"2025-10-21T12:41:26+00:00","dateModified":"2025-11-12T17:52:06+00:00","breadcrumb":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en#primaryimage","url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-Dr-Tabrizian-ENG-1.png","contentUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/10\/Annonce-Dr-Tabrizian-ENG-1.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/10\/21\/establishing-a-platform-to-innovate-therapeutic-vaccines-using-immunomodulatory-nanoparticles-derived-from-bacterial-lipids-against-cancer\/?lang=en#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/medicamentquebec.ca\/"},{"@type":"ListItem","position":2,"name":"Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles"}]},{"@type":"WebSite","@id":"https:\/\/medicamentquebec.ca\/#website","url":"https:\/\/medicamentquebec.ca\/","name":"M\u00e9dicament Qu\u00e9bec","description":"","publisher":{"@id":"https:\/\/medicamentquebec.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicamentquebec.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/medicamentquebec.ca\/#organization","name":"M\u00e9dicament Qu\u00e9bec","url":"https:\/\/medicamentquebec.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/","url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","contentUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","width":494,"height":266,"caption":"M\u00e9dicament Qu\u00e9bec"},"image":{"@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/person\/f380269566615a205fb9c18904b8b89f","name":"St\u00e9phanie Bilodeau","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","caption":"St\u00e9phanie Bilodeau"},"url":"https:\/\/medicamentquebec.ca\/index.php\/author\/bilodeaus\/"}]}},"_links":{"self":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/comments?post=2955"}],"version-history":[{"count":3,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2955\/revisions"}],"predecessor-version":[{"id":3021,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2955\/revisions\/3021"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/media\/2951"}],"wp:attachment":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/media?parent=2955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/categories?post=2955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/tags?post=2955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}